CD40LG and plasma cell myeloma: In turn, Young et al. [81] have suggested that the loss of CD154 expression on the myeloma cells leads to the ligand-dependent loss of epithelial growth regulation and uncontrolled inflammations and infections, which may contribute to the increased and uncontrolled susceptibility of patients to the development of cancer.